David Henkel

Inkine Pharmaceutical Co., Inc. develops pharmaceutical products. The firm's products include Visicol(R) and IBStat(R). Its products are used for diagnosis and treatment of gastrointestinal disorders. The company was founded by Leonard S. Jacob in 1970 and is headquartered in Blue Bell, PA.

Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY.

Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia.

Greater Cleveland Partnership is a business membership association. The firm offers resources include project management, asset to capital, real estate site searches, incentive workforce program assistance and workforce grants assistance. The company was founded in March 2004 and is headquartered in Cleveland, OH.

ArtsinStark supports and promotes arts throughout Stark County. The company is headquartered in Canton, OH.

Part of Squire Patton Boggs (US) LLP, Squire, Sanders & Dempsey LLP (Florida) is a company based in Miami, FL.

Towards Employment, Inc. offers workforce development services. The company was founded in 1976 and is headquartered in Cleveland, OH.

The City Club Forum Foundation engages in educational trust management. The company was founded on August 3, 1940 and is headquartered in Cleveland, OH.

The Abraham J. The Cleveland Cord Blood Center research and development laboratory, led by Satyabrata Sinha, Ph.D., is exploring innovative ways to combat these debilitating diseases. The non-profit company is based in Cleveland, OH and was founded in 2008 by Mary J. Laughlin. & Phyllis Katz Cord Blood Foundation is a not-for-profit 501(c)(3) organization that serves as a leader in the collection, processing, storage, and distribution of quality cord blood stem cell units for a diverse population's unmet needs. The foundation focuses on providing cord blood stem cells for individuals with type 1 diabetes and Parkinson's disease.

Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on September 30, 2008 and is headquartered in Toronto, Canada.